Page last updated: 2024-10-21

n-methyl-3,4-methylenedioxyamphetamine and Enlarged Liver

n-methyl-3,4-methylenedioxyamphetamine has been researched along with Enlarged Liver in 1 studies

N-Methyl-3,4-methylenedioxyamphetamine: An N-substituted amphetamine analog. It is a widely abused drug classified as a hallucinogen and causes marked, long-lasting changes in brain serotonergic systems. It is commonly referred to as MDMA or ecstasy.
3,4-methylenedioxymethamphetamine : A member of the class of benzodioxoles that is 1,3-benzodioxole substituted by a 2-(methylamino)propyl group at position 5.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Taş, A1
Kara, B1
Yılmaz, C1
Suat Yalçın, M1
Dilek, O1
Olmez, S1
Saritas, B1

Other Studies

1 other study available for n-methyl-3,4-methylenedioxyamphetamine and Enlarged Liver

ArticleYear
Fulminant Budd-Chiari syndrome due to ecstasy.
    Clinics and research in hepatology and gastroenterology, 2017, Volume: 41, Issue:1

    Topics: Adult; Ascites; Budd-Chiari Syndrome; Diagnosis, Differential; Hallucinogens; Hepatomegaly; Humans;

2017